Ernexa Therapeutics Inc. (ERNA) Receivables (2010 - 2025)
Ernexa Therapeutics' (ERNA) quarterly Receivables came in at -$58000.0 in Q4 2025, down 123.2% YoY from $250000.0 in Q4 2024, and down 123.2% on a QoQ basis from $250000.0 in Q4 2024.
Ernexa Therapeutics Inc. (ERNA) Receivables (2010 - 2025) Analysis & Trends
Ernexa Therapeutics (ERNA) has 16 years of Receivables data on file, last reported at -$58000.0 in Q4 2025.
- Quarterly Receivables fell 123.2% year-over-year to -$58000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$58000.0 (down 123.2% YoY) and the FY2025 annual result came in at $750000.0, up 71.62% from the prior year.
- Receivables retreated to -$58000.0 in Q4 2025, from $250000.0 in the prior quarter.
- In the past five years, Receivables ranged from a high of $1.3 million in Q4 2021 to a low of -$1.4 million in Q4 2023.
- A 5-year average of $38986.3 and a median of $22959.0 in 2021 frame the typical range for Receivables.
- Annual changes were most pronounced in 2021 — Receivables surged 1103.57% — and 2023, when it sank 5508.0%.
- Tracing ERNA's Receivables over 5 years: stood at $1.3 million in 2021, then sank by 98.15% to $25000.0 in 2022, then slumped by 5508.0% to -$1.4 million in 2023, then soared by 118.49% to $250000.0 in 2024, then plunged by 123.2% to -$58000.0 in 2025.
- The last three Receivables figures came in at -$58000.0 (Q4 2025), $250000.0 (Q4 2024), and -$1.4 million (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -58,000.00 |
| Dec 31, 2024 | 250,000.00 |
| Dec 31, 2023 | -1.35 Mn |
| Dec 31, 2022 | 25,000.00 |
| Dec 31, 2021 | 1.35 Mn |
| Mar 31, 2021 | 20,918.00 |
| Dec 31, 2020 | 112,000.00 |
| Sep 30, 2020 | 132,000.00 |
| Mar 31, 2020 | 383,000.00 |
| Dec 31, 2019 | 1.35 Mn |
| Sep 30, 2019 | 777,000.00 |
| Jun 30, 2019 | 732,000.00 |
| Mar 31, 2019 | 158,000.00 |
| Dec 31, 2018 | 1.70 Mn |
| Sep 30, 2018 | 1.28 Mn |
| Jun 30, 2018 | 787,000.00 |
| Mar 31, 2018 | 1.03 Mn |
| Dec 31, 2017 | 714,000.00 |
| Sep 30, 2017 | 627,000.00 |
| Jun 30, 2017 | 761,000.00 |